Literature DB >> 22752157

VRK2 anchors KSR1-MEK1 to endoplasmic reticulum forming a macromolecular complex that compartmentalizes MAPK signaling.

Isabel F Fernández1, Luis G Pérez-Rivas, Sandra Blanco, Adrián A Castillo-Dominguez, José Lozano, Pedro A Lazo.   

Abstract

The spatial and temporal regulation of intracellular signaling is determined by the spatial and temporal organization of complexes assembled on scaffold proteins, which can be modulated by their interactions with additional proteins as well as subcellular localization. The scaffold KSR1 protein interacts with MAPK forming a complex that conveys a differential signaling in response to growth factors. The aim of this work is to determine the unknown mechanism by which VRK2A downregulates MAPK signaling. We have characterized the multiprotein complex formed by KSR1 and the Ser-Thr kinase VRK2A. VRK2A is a protein bound to the endoplasmic reticulum (ER) and retains a fraction of KSR1 complexes on the surface of this organelle. Both proteins, VRK2A and KSR1, directly interact by their respective C-terminal regions. In addition, MEK1 is also incorporated in the basal complex. MEK1 independently interacts with the CA5 region of KSR1 and with the N-terminus of VRK2A. Thus, VRK2A can form a high molecular size (600-1,000 kDa) stable complex with both MEK1 and KSR1. Knockdown of VRK2A resulted in disassembly of these high molecular size complexes. Overexpression of VRK2A increased the amount of KSR1 in the particulate fraction and prevented the incorporation of ERK1/2 into the complex after stimulation with EGF. Neither VRK2A nor KSR1 interact with the VHR, MKP1, MKP2, or MKP3 phosphatases. The KSR1 complex assembled and retained by VRK2A in the ER can have a modulatory effect on the signal mediated by MAPK, thus locally affecting the magnitude of its responses, and can explain differential responses depending on cell type.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22752157     DOI: 10.1007/s00018-012-1056-8

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  51 in total

Review 1.  Roles of VRK1 as a new player in the control of biological processes required for cell division.

Authors:  Alberto Valbuena; Marta Sanz-García; Inmaculada López-Sánchez; Francisco M Vega; Pedro A Lazo
Journal:  Cell Signal       Date:  2011-04-14       Impact factor: 4.315

Review 2.  MAPKAP kinases - MKs - two's company, three's a crowd.

Authors:  Matthias Gaestel
Journal:  Nat Rev Mol Cell Biol       Date:  2006-02       Impact factor: 94.444

Review 3.  MAP kinases and the control of nuclear events.

Authors:  A G Turjanski; J P Vaqué; J S Gutkind
Journal:  Oncogene       Date:  2007-05-14       Impact factor: 9.867

4.  VRK2 inhibits mitogen-activated protein kinase signaling and inversely correlates with ErbB2 in human breast cancer.

Authors:  Isabel F Fernández; Sandra Blanco; José Lozano; Pedro A Lazo
Journal:  Mol Cell Biol       Date:  2010-08-02       Impact factor: 4.272

Review 5.  Regulation of MAP kinases by the VHR dual-specific phosphatase: implications for cell growth and differentiation.

Authors:  Fabio Cerignoli; Souad Rahmouni; Ze'ev Ronai; Tomas Mustelin
Journal:  Cell Cycle       Date:  2006-10-01       Impact factor: 4.534

6.  The human vaccinia-related kinase 1 (VRK1) phosphorylates threonine-18 within the mdm-2 binding site of the p53 tumour suppressor protein.

Authors:  S Lopez-Borges; P A Lazo
Journal:  Oncogene       Date:  2000-07-27       Impact factor: 9.867

7.  Nm23-H1 metastasis suppressor expression level influences the binding properties, stability, and function of the kinase suppressor of Ras1 (KSR1) Erk scaffold in breast carcinoma cells.

Authors:  Massimiliano Salerno; Diane Palmieri; Amina Bouadis; Douglas Halverson; Patricia S Steeg
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

Review 8.  Role of calcineurin in neurodegeneration produced by misfolded proteins and endoplasmic reticulum stress.

Authors:  Abhisek Mukherjee; Claudio Soto
Journal:  Curr Opin Cell Biol       Date:  2011-02-02       Impact factor: 8.382

9.  The ERK Cascade: Distinct Functions within Various Subcellular Organelles.

Authors:  Inbal Wortzel; Rony Seger
Journal:  Genes Cancer       Date:  2011-03

10.  A ceramide-binding C1 domain mediates kinase suppressor of ras membrane translocation.

Authors:  Xianglei Yin; Mohammad Zafrullah; Hyunmi Lee; Adriana Haimovitz-Friedman; Zvi Fuks; Richard Kolesnick
Journal:  Cell Physiol Biochem       Date:  2009-08-03
View more
  17 in total

1.  Common variants on 2p16.1, 6p22.1 and 10q24.32 are associated with schizophrenia in Han Chinese population.

Authors:  H Yu; H Yan; J Li; Z Li; X Zhang; Y Ma; L Mei; C Liu; L Cai; Q Wang; F Zhang; N Iwata; M Ikeda; L Wang; T Lu; M Li; H Xu; X Wu; B Liu; J Yang; K Li; L Lv; X Ma; C Wang; L Li; F Yang; T Jiang; Y Shi; T Li; D Zhang; W Yue
Journal:  Mol Psychiatry       Date:  2016-12-06       Impact factor: 15.992

2.  The Vaccinia Virus (VACV) B1 and Cellular VRK2 Kinases Promote VACV Replication Factory Formation through Phosphorylation-Dependent Inhibition of VACV B12.

Authors:  Amber B Rico; Zhigang Wang; Annabel T Olson; Alexandria C Linville; Brianna L Bullard; Eric A Weaver; Clinton Jones; Matthew S Wiebe
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

3.  Ultrastructural study of spermatogenesis in KSR2 deficient mice.

Authors:  Elena Moretti; Giulia Collodel; Lucia Mazzi; Ilaria Russo; Emanuele Giurisato
Journal:  Transgenic Res       Date:  2015-06-09       Impact factor: 2.788

4.  Deletion of the Vaccinia Virus B1 Kinase Reveals Essential Functions of This Enzyme Complemented Partly by the Homologous Cellular Kinase VRK2.

Authors:  Annabel T Olson; Amber B Rico; Zhigang Wang; Gustavo Delhon; Matthew S Wiebe
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

5.  Human VRK2 (vaccinia-related kinase 2) modulates tumor cell invasion by hyperactivation of NFAT1 and expression of cyclooxygenase-2.

Authors:  Marta Vázquez-Cedeira; Pedro A Lazo
Journal:  J Biol Chem       Date:  2012-10-26       Impact factor: 5.157

6.  VRK2 is involved in the innate antiviral response by promoting mitostress-induced mtDNA release.

Authors:  Wen-Rui He; Li-Bo Cao; Yu-Lin Yang; Duo Hua; Ming-Ming Hu; Hong-Bing Shu
Journal:  Cell Mol Immunol       Date:  2021-03-30       Impact factor: 11.530

7.  Sensitivity of the kinase activity of human vaccinia-related kinase proteins to toxic metals.

Authors:  Iria Barcia-Sanjurjo; Marta Vázquez-Cedeira; Ramiro Barcia; Pedro A Lazo
Journal:  J Biol Inorg Chem       Date:  2013-03-13       Impact factor: 3.862

8.  VRK2 identifies a subgroup of primary high-grade astrocytomas with a better prognosis.

Authors:  Irene Rodríguez-Hernández; Marta Vázquez-Cedeira; Angel Santos-Briz; Juan L García; Isabel F Fernández; Juan A Gómez-Moreta; Javier Martin-Vallejo; Rogelio González-Sarmiento; Pedro A Lazo
Journal:  BMC Clin Pathol       Date:  2013-10-01

9.  Human VRK2 modulates apoptosis by interaction with Bcl-xL and regulation of BAX gene expression.

Authors:  D M Monsalve; T Merced; I F Fernández; S Blanco; M Vázquez-Cedeira; P A Lazo
Journal:  Cell Death Dis       Date:  2013-02-28       Impact factor: 8.469

10.  Rare Genomic Variants Link Bipolar Disorder with Anxiety Disorders to CREB-Regulated Intracellular Signaling Pathways.

Authors:  Berit Kerner; Aliz R Rao; Bryce Christensen; Sugandha Dandekar; Michael Yourshaw; Stanley F Nelson
Journal:  Front Psychiatry       Date:  2013-11-28       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.